BioReliance® End-to-End Solutions For Accelerated Process Development

Source: MilliporeSigma

MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. BioReliance® End-to-End Solutions encompasses service and support for both emerging biotech and major biopharmaceutical companies that seek to accelerate process development, clinical drug production, and conceptual facilities design. We operate our own in-house bioproduction facilities and convey our expertise to clients as they progress on their drug development journey, with an emphasis on single-use technologies and high-performance upstream and downstream systems. For more information visit